Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | SYNH | Class A Common Stock | 17.9K | Aug 25, 2022 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Includes (i) 2,890 shares of restricted stock units ("RSUs") that vest on January 15, 2023; (ii) 1,443 RSUs that vest on January 18, 2023; (iii) 468 RSUs that vest on June 15, 2023; (iv) 1,739 RSUs that vest on January 15, 2024; (v) 1,443 RSUs that vest on January 18, 2024; (vi) 468 RSUs that vest on June 15, 2024; (vii) 1,444 RSUs that vest on January 18, 2025; and (viii) 468 RSUs that vest on June 15, 2025, all subject to continued employment. |
F2 | Includes (i) 305 performance restricted stock units ("PRSUs") that were earned based upon performance criteria for the year ended December 31, 2020 and will vest in full once the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. determines the attainment level of the performance goals for the year ended December 31, 2022, subject to continued employment; (ii) 582 PRSUs that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2022, subject to continued employment; and (iii) 982 PRSUs that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment. |